Skip to main content
Category

Rheumatoid Arthritis

Disruptions in Rheumatology Care and the Rise of Telehealth in Response to the COVID-19 Pandemic in a Community Practice–Based Network

Information on COVID-19 rapidly emerged and expanded at the onset of the pandemic. As of May 2020 it included 17,998 publications. Over 1,500 of those publications addressed rheumatic disease-related topics. The purpose of this review is to identify specific threats to the validity of the COVID-19 literature and to recommend resources for practicing rheumatologists and their patients.

Read More

Assessing RA Disease Activity with Promis Measures Using Digital Technology

American College of Rheumatology Journals logo

In Arthritis Care & Research, Yun et al. report using the National Institutes of Health Patient-Reported Outcomes Measurement Information System (PROMIS) instruments in substitution for lengthier Patient-Reported Outcomes instruments such as the Routine Assessment of Patient Index Data 3 (RAPID3). 6,154 eligible patients contributed 11,275 observations using 4 PROMIS computer-adaptive testing instruments and the RAPID3. There was excellent agreement between the observed RAPID3 and predicted RAPID3 scores estimated using several PROMIS instruments. PROMIS may be used in place of RAPID3 and other patient global assessment components.

Read More

Patient Perceptions of Unmet Medical Need in Rheumatoid Arthritis: A Cross-Sectional Survey in the USA

This article published in Rheumatology and Therapy by Radawski et al. identifies and quantifies the unmet needs perceived by United States patients with Rheumatoid Arthritis (RA) currently taking a disease-modifying antirheumatic drug (DMARD). 258 patients were surveyed and only 26% of patients reported that they were satisfied with their RA treatment. Patients not satisfied with their treatment reported higher rheumatic disease impact and half reported a current flare. There is a need for improved disease management among RA patients.

Read More

Digital Tracking of Rheumatoid Arthritis Longitudinally (Digital) Using Biosensor and Patient-Reported Outcome Data: Protocol for a Real-World Study

National Library of Medicine logo

This is a proposal for a study to see if wearable digital technology that enables the regular passive collection of patients’ biometric and activity data is strongly related to data captured by patient-reported outcome measures. Participants in this study will be observed for a period of 6 months and will be registrants of ArthritisPower. The results of this study are expected to be published by the end of 2021.

Read More

Contraception methods used by women with rheumatoid arthritis and psoriatic arthritis

In Clinical Rheumatology, Leverenz et al. report a study in which they investigated contraceptive methods used in young women with Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA) and correlated the efficacy of the contraceptive methods with the use of concomitant rheumatic medications. Of the 164 women included, women with RA and PsA reported similar utilization of highly effective contraception methods and effective methods, but different utilization of ineffective methods and no methods. These proportions remained similar across subgroups taking methotrexate, anti-TNF biologics, and novel medications. Women with PsA were more likely to report no methods of contraception.

Read More

Preference Phenotypes Can Be Used to Support Shared Decision-Making at Point-of-Care for Patients with Rheumatoid Arthritis: A Proof of Concept Study

Hsiao et al. conducted a pretest/post test study with RA patients who had outpatient visits using 5 phenotypic groups that clarified patient desires. Clinicians were introduced to the phenotypic groups. The authors found greater evidence of shared decision-making in the post test phase of the study as patients were offered more choices and more visits in which patients vocalized their values and/or preferences and providers were more likely to base their recommendations on patients’ values and/or preferences. Allowing patients to consider a set of preference phenotypes can support shared decision-making.

Read More

Barriers to Treatment Optimization and Achievement of Patients’ Goals: Perspectives from People Living with Rheumatoid Arthritis Enrolled in the Arthritispower Registry.

In Arthritis Research & Therapy, Gavigan et al. report on Rheumatoid Arthritis (RA) patients’ beliefs on factors that influence their physician’s treatment decisions, reasons patients tolerate sub-optimal disease control, and perceived barriers to treatment optimization. Eligible participants were enrolled in the ArthritisPower registry and completed a survey on barriers to treatment optimization and patient-reported outcomes on symptoms of fatigue, sleep disturbance, and physical function. Most participants trusted their doctor’s treatment decisions and prioritized their physician’s treatment goals over their own.

Read More